Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sucampo Pharmaceuticals Inc (NASDAQ:SCMP)

11.40
Delayed Data
As of Jan 20
 -0.05 / -0.44%
Today’s Change
9.59
Today|||52-Week Range
17.55
-15.87%
Year-to-Date
Synergy (SGYP) Trulance Wins FDA Approval for Constipation
Jan 20 / Zacks.com - Paid Partner Content
TherapeuticsMD's Rejoice Study Data Published in Journal
Jan 12 / Zacks.com - Paid Partner Content
Allergan (AGN) Rhofade Cream for Rosacea Approved in U.S.
Jan 20 / Zacks.com - Paid Partner Content
Merck KGaA, Vertex Announce Tie-Up for Oncology Programs
Jan 12 / Zacks.com - Paid Partner Content
Apricus (APRI) Stock Gains on Vitaros' Approval in Mexico
Jan 19 / Zacks.com - Paid Partner Content
Mylan/Biocon's Herceptin Biosimilar under Review in the U.S.
Jan 12 / Zacks.com - Paid Partner Content
Bioblast (ORPN) SCA3 Drug Favorable in Phase IIa Study
Jan 19 / Zacks.com - Paid Partner Content
Valeant Streamlines Portfolio with Skincare Brands Sale
Jan 11 / Zacks.com - Paid Partner Content
Agenus, NCI Ink Deal to Evaluate Prophage-Keytruda Combo
Jan 18 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Sucampo Pharmaceuticals, Insulet, Western Refining...
Jan 11 / Zacks.com - Paid Partner Content
Benitec Stock Up on Orphan Drug Status for BB-301 in EU
Jan 18 / Zacks.com - Paid Partner Content
Novo Nordisk (NVO) Fiasp Gets EU Nod for Diabetes in Adults
Jan 11 / Zacks.com - Paid Partner Content
Mid-Morning Market Update: Markets Open Lower; Morgan Stanley Tops Q4 Estimates
Jan 17 / Benzinga - Paid Partner Content
5 Underperformers of 2016: Turnaround Story in 2017?
Jan 10 / Zacks.com - Paid Partner Content
Zacks.com featured highlights: Glaukos, Daqo New Energy, Calavo Growers and Sucampo P...
Jan 17 / Zacks.com - Paid Partner Content
Valeant to Sell Dendreon Unit to Sanpower for $820 Million
Jan 10 / Zacks.com - Paid Partner Content
Key FDA Events to Watch Out for in Q1
Jan 17 / Zacks.com - Paid Partner Content
Roche Gets Priority Review for Immunotherapy Drug Tecentriq
Jan 10 / Zacks.com - Paid Partner Content
Novartis to Conduct Trial on Obese, Type II Diabetes Patients
Jan 13 / Zacks.com - Paid Partner Content
Zacks.com featured highlights: NVIDIA, Sucampo Pharmaceuticals, Calavo Growers, Tucow...
Jan 10 / Zacks.com - Paid Partner Content
Coherus Offers Positive Phase III Data on Humira Biosimilar
Jan 13 / Zacks.com - Paid Partner Content
Merrimack (MACK) Sells Onivyde Rights to Ipsen for $1B
Jan 09 / Zacks.com - Paid Partner Content
TESARO Varubi IV Gets Complete Response Letter in the U.S.
Jan 13 / Zacks.com - Paid Partner Content
Go Driehaus Way: 5 Momentum Picks
Jan 09 / Zacks.com - Paid Partner Content